Skip to main content
Fig. 1 | Fluids and Barriers of the CNS

Fig. 1

From: Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Fig. 1

Design of the studies displaying treatments given and sample collections used in this paper. The bar shows the transition from the Intrathecal Treatment Trial in Progressive Multiple Sclerosis (ITT-PMS) to the follow-up extension study, with time shown below in months. Black arrows display points of treatment. Scalpel indicates implantation of Ommaya reservoir and collection of ventricular CSF during surgery, and test tubes indicate collection of paired lumbar and ventricular CSF. MD, microdialysis; n, number of participants

Back to article page